Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.
Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, Cassinotti A, Cazzola P, Markopoulos K, Massari A, Rosti V, Porro GB, Corazza GR. Bergamaschi G, et al. Among authors: porro gb. Haematologica. 2010 Feb;95(2):199-205. doi: 10.3324/haematol.2009.009985. Epub 2009 Oct 8. Haematologica. 2010. PMID: 19815838 Free PMC article.
Vitamin D and inflammatory bowel disease.
Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB. Ardizzone S, et al. Among authors: porro gb. Vitam Horm. 2011;86:367-77. doi: 10.1016/B978-0-12-386960-9.00016-2. Vitam Horm. 2011. PMID: 21419280 Review.
Perianal Crohn's disease: overview.
Ardizzone S, Porro GB. Ardizzone S, et al. Among authors: porro gb. Dig Liver Dis. 2007 Oct;39(10):957-8. doi: 10.1016/j.dld.2007.07.152. Epub 2007 Aug 27. Dig Liver Dis. 2007. PMID: 17723323 Review. No abstract available.
Extraintestinal manifestations of inflammatory bowel disease.
Ardizzone S, Puttini PS, Cassinotti A, Porro GB. Ardizzone S, et al. Among authors: porro gb. Dig Liver Dis. 2008 Jul;40 Suppl 2:S253-9. doi: 10.1016/S1590-8658(08)60534-4. Dig Liver Dis. 2008. PMID: 18598997 Review.
Is it possible to modify the clinical course of Crohn's disease?
Ardizzone S, Porro GB. Ardizzone S, et al. Among authors: porro gb. Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):428-9. doi: 10.1038/ncpgasthep1178. Epub 2008 Jun 17. Nat Clin Pract Gastroenterol Hepatol. 2008. PMID: 18560396 No abstract available.
Immunomodulators for all patients with inflammatory bowel disease?
Ardizzone S, Cassinotti A, Manes G, Porro GB. Ardizzone S, et al. Among authors: porro gb. Therap Adv Gastroenterol. 2010 Jan;3(1):31-42. doi: 10.1177/1756283X09354136. Therap Adv Gastroenterol. 2010. PMID: 21180588 Free PMC article.
Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease.
Di Sabatino A, Biancheri P, Piconese S, Rosado MM, Ardizzone S, Rovedatti L, Ubezio C, Massari A, Sampietro GM, Foschi D, Porro GB, Colombo MP, Carsetti R, MacDonald TT, Corazza GR. Di Sabatino A, et al. Among authors: porro gb. Inflamm Bowel Dis. 2010 Nov;16(11):1891-7. doi: 10.1002/ibd.21271. Inflamm Bowel Dis. 2010. PMID: 20848485
65 results